Literature DB >> 8852482

Long-term results in patients with Lyme arthritis following treatment with ceftriaxone.

H Valesová1, J Mailer, J Havlík, D Hulínská, J Hercogová.   

Abstract

A total of 35 patients with late stage Lyme borreliosis with involvement of the joints was followed up until 3 years after a 14 day course of 2 g ceftriaxone once daily i.v. Diagnosis was confirmed by indirect and direct microbiological methods as well as clinical signs and symptoms. Long term clinical results in 26 patients at 36 months were complete response or marked improvement in 19, relapse in six and new manifestations in four of the cases, respectively. Possible mechanisms for non-responding to therapy are discussed. Therapy was well tolerated; in no case discontinuation of treatment was necessary due to adverse drug reactions. The treatment results in this group of 35 patients with Lyme arthritis are considered successful. The data obtained are consistent with expectations based on the published experiences with ceftriaxone in this indication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852482     DOI: 10.1007/bf01780670

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  21 in total

1.  Long term treatment of chronic Lyme arthritis with benzathine penicillin.

Authors:  M A Cimmino; S Accardo
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

2.  Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis.

Authors:  D Hassler; K Riedel; J Zorn; V Preac-Mursic
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

3.  Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles.

Authors:  A C Steere; E Dwyer; R Winchester
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis.

Authors:  J Schmidli; T Hunziker; P Moesli; U B Schaad
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

5.  Lyme arthritis: clinical features, serological, and radiographic findings of cases in Germany.

Authors:  P Herzer; B Wilske; V Preac-Mursic; G Schierz; M Schattenkirchner; N Zöllner
Journal:  Klin Wochenschr       Date:  1986-03-03

6.  Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial.

Authors:  E M Caperton; K L Heim-Duthoy; G R Matzke; P K Peterson; R C Johnson
Journal:  Arch Intern Med       Date:  1990-08

7.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

Review 8.  Current recommendations for the treatment of Lyme disease.

Authors:  L H Sigal
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

9.  Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis.

Authors:  T Häupl; G Hahn; M Rittig; A Krause; C Schoerner; U Schönherr; J R Kalden; G R Burmester
Journal:  Arthritis Rheum       Date:  1993-11

10.  Electron microscopy and the polymerase chain reaction of spirochetes from the blood of patients with Lyme disease.

Authors:  D Hulínská; M Krausová; D Janovská; H Rohácová; J Hancil; H Mailer
Journal:  Cent Eur J Public Health       Date:  1993-12       Impact factor: 1.163

View more
  4 in total

Review 1.  Antibiotic treatment of Lyme borreliosis: what is the evidence?

Authors:  R Dinser; M C Jendro; S Schnarr; H Zeidler
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

2.  Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis.

Authors:  B Jaulhac; R Heller; F X Limbach; Y Hansmann; D Lipsker; H Monteil; J Sibilia; Y Piémont
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic.

Authors:  Marcus Davidsson
Journal:  Healthcare (Basel)       Date:  2018-02-13

Review 4.  A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis.

Authors:  Michelle A E Brouwer; Freek R van de Schoor; Hedwig D Vrijmoeth; Mihai G Netea; Leo A B Joosten
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.